Amit Kumar

Amit Kumar is a seasoned executive with extensive experience in the biotechnology sector and leadership roles across various organizations. Currently serving as Chairman and CEO of Anixa Biosciences, Inc., Amit oversees the development of innovative immunotherapies and cancer diagnostics. Additionally, as Chairman and Co-Founder of EdisonXFC, Amit is focused on expanding a network of fast charging stations for electric vehicles. Involvement with the American Cancer Society includes membership on the Regional Board of Directors, following a tenure on the National Board from 2017 to 2022. Previously, Amit held responsibilities as Executive Chairman and Co-Founder of Actym Therapeutics, led GFF as President and CEO, and rang as President and CEO of CombiMatrix Corporation, where a successful public offering occurred in 2002. Amit's educational credentials include a PhD in Physical Chemistry from Caltech and a Postdoctoral Fellowship at Harvard University.